Journal Logo

Articles by Y. A. Efebera

ANCHOR (OP-104): A PHASE 1 STUDY UPDATE OF MELFLUFEN AND DEXAMETHASONE PLUS BORTEZOMIB OR DARATUMUMAB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS REFRACTORY TO AN IMID OR A PROTEASOME INHIBITOR: PF608

Pour, L.; Efebera, Y. A.; Granell, M.; More

HemaSphere. 3:257-258, June 2019.